GLG Life Tech Corporation Announces Fourth Letter of No Objection Issued by FDA for RebPure(TM) 95 Stevia Extract
2011年12月5日 - 8:30PM
GLG Life Tech Corporation (Nasdaq:GLGL) (TSX:GLG) ("GLG" or the
"Company"), the vertically-integrated leader in the agricultural
and commercial development of high quality stevia and all natural
and zero calorie food and beverage products, announces the United
States Food and Drug Administration ("FDA") has issued a Generally
Recognized as Safe (GRAS) Letter of No Objection for GLG's high
purity stevia extract, RebPure™ RA95 (Filing No. GRN000380), which
contains greater than 95% Rebaudioside A (RA) and 97% of steviol
glycosides.
The GRAS process is a legal and FDA-approved process that allows
companies to conduct their own GRAS determinations by consulting
with an independent panel of scientists to determine if an
ingredient meets the FDA's criteria for safety. To ensure even
further confidence in its products, GLG has submitted its dossier
to the FDA for review which has resulted in this Letter of No
Objection.
Dr. Luke Zhang, Chairman and CEO of GLG stated, "We had
previously received three Letters of No Objection for our
high-purity stevia extracts: the RebPure™ 97, the PureSTV™ and
BlendSure™. With this fourth letter, we now have a letter of no
objection to support our RebPure™ 95 product. These four letters
from the FDA also affirms our long-term commitment to provide our
customers with the highest quality standards of stevia extracts in
the United States and around the world and positions GLG as the
only company in the world to produce high purity RA, STV and
BlendSureTM products backed by the requisite letters of no
objection from the FDA. Rebaudioside A (RA) and Stevioside (STV)
are the two major components from the stevia plant and the GLG
R&D and production teams have been working on know-how
technologies and patents to produce high purity RA and STV as well
as the blend of RA and STV stevia extracts since 2001. These four
letters will allow our RA, STV and BlendSureTM stevia extracts to
be utilized in many of our AN0CTM beverage and foods. We have found
that the FDA GRAS standard is respected in many of our key
international markets including South America and Asia and we will
therefore be able to further leverage this key achievement in our
international markets."
About GLG Life Tech Corporation
GLG Life Tech Corporation (Nasdaq:GLGL) (TSX:GLG) is the global
leader for the supply of high purity stevia extracts, an
all-natural, zero-calorie sweetener used in food and beverages. The
Company's vertically integrated operations cover each step in the
stevia supply chain including; non-GMO stevia seed breeding;
natural propagation; stevia leaf growth and harvest; proprietary
extraction and refining; marketing and distribution of our stevia
extract; and the formulation and distribution of consumer finished
goods. GLG's advanced technology, extraction technique and premier,
high quality product offerings make it a leading producer of high
purity, great tasting stevia extracts. For further information,
please visit www.glglifetech.com.
The GLG Life Tech Corporation logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=7994
Forward-looking statements: This press release
contains certain information that may constitute "forward-looking
information" and "forward-looking statements" within the meaning of
applicable Canadian and United States securities laws. All
statements relating to plans, strategies, projections of results of
specific activities or investments, and other statements that are
not descriptions of historical facts may be forward-looking
statements. Forward-looking statements and information are
inherently subject to risks and uncertainties, and actual results
could differ materially from those currently anticipated due to a
number of factors, which include, but are not limited to,
operational risks, the effects of general economic conditions,
changing foreign exchange rates and actions by government
authorities, uncertainties associated with legal proceedings and
negotiations, industry supply levels, competitive pricing pressures
and other risks and uncertainties disclosed in the public documents
filed by the Company with Canadian and United States securities
regulatory authorities. Forward-looking statements and information
may be identified by terms such as "may", "will", "should",
"continue", "expect", "anticipate", "estimate", "believe",
"intend", "plan" or "project", or similar terms or the negatives of
these terms. Although we believe that the expectations reflected in
the forward-looking statements and information are reasonable, we
cannot guarantee future results, levels of activity, performance,
or achievements. The Company's forward-looking statements and
information reflect the beliefs, opinions and projections on the
date the statements are made. The Company assumes no obligation to
update forward-looking information should circumstances or
management's estimates or opinions change, except as required by
law.
CONTACT: Sophia Luke
Vice President of Investor Relations
GLG Life Tech Corporation
+1 (604) 669-2602 Ext 104
ir@glglifetech.com
Glg Life Tech Corp (MM) (NASDAQ:GLGL)
過去 株価チャート
から 5 2024 まで 6 2024
Glg Life Tech Corp (MM) (NASDAQ:GLGL)
過去 株価チャート
から 6 2023 まで 6 2024